FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.2  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Cyproterone 50mg tablets (Stragen UK Ltd) 168 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cyproterone 100mg tablets (Stragen UK Ltd) 84 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cyproterone 100mg tablets (Stragen UK Ltd) 84 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 1 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 84 tablet 3 x 28 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 84 tablet 3 x 28 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 168 tablet 6 x 28 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 168 tablet 6 x 28 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 5mg tablets (Rivopharm (UK) Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 5mg tablets (Rivopharm (UK) Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 10mg tablets (Rivopharm (UK) Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 10mg tablets (Rivopharm (UK) Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 15mg tablets (Rivopharm (UK) Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 15mg tablets (Rivopharm (UK) Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 30mg tablets (Rivopharm (UK) Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 30mg tablets (Rivopharm (UK) Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Atorvastatin 40mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Atorvastatin 40mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Atorvastatin 80mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Atorvastatin 80mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Methyldopa 125mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Methyldopa 125mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prednisolone 2.5mg gastro-resistant tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prednisolone 2.5mg gastro-resistant tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Voriconazole 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Voriconazole 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Metoclopramide 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metoclopramide 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Memantine 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Memantine 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Levocetirizine 5mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Levocetirizine 5mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Letrozole 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Letrozole 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Levocetirizine 5mg tablets 60 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Levocetirizine 5mg tablets 60 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Atorvastatin 40mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Atorvastatin 40mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Atorvastatin 80mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Atorvastatin 80mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Methyldopa 125mg tablets (Bristol Laboratories Ltd) 56 tablet 4 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Methyldopa 125mg tablets (Bristol Laboratories Ltd) 56 tablet 4 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prednisolone 2.5mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prednisolone 2.5mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Voriconazole 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Voriconazole 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) 1 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) 8 tablet 2 x 4 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) 8 tablet 2 x 4 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) 1 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Metoclopramide 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metoclopramide 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Memantine 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Memantine 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 324 of 342 Next End

    This concept is not in any reference sets

    Back to Start